The concept of cardiometabolic risk: Bridging the fields of diabetology and cardiology
Open accessThe DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
The lack of physical activity and the adoption of poor nutritional habits is the major cause of the obesity epidemic that is currently sweeping the world. The expansion of adipose tissue mass, especially of the visceral adipose tissue depot, is observed in the vast majority of individuals carrying the clinical features of the metabolic syndrome, an important (and reversible) risk factor of type 2 diabetes and cardiovascular disease. As waist circumference can be used as a crude estimate of visceral fat accumulation, its measurement provides further information on cardiovascular and type 2 diabetes risk, at any given body mass index value. However, an elevated waist circumference might also be the result of an increased 'cardioprotective' subcutaneous adipose tissue mass. We have proposed that the measurement of plasma triglycerides along with waist circumference, the so-called 'hypertriglyceridemic waist' might better quantify visceral obesity and its health hazards than waist circumference alone. "Hypertriglyceridemic waist" is thought to represent an altered, dysfunctional, and highly lipolytic adipose tissue that is a major culprit abnormality behind the metabolic syndrome and associated cardiometabolic risk, independently from classical cardiovascular disease risk factors such as age, sex, and plasma low density lipoprotein (LDL) cholesterol levels.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The metabolic syndrome—a new worldwide definition
Alberti, K. G. M., Zimmet, P., & Shaw, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67402-8 · Cited by 9,352 · cited 1×
“clustering of risk factors/markers (16).”
Haffner, S. M., Lehto, S., Rönnemaa, T., Pyörälä, K., & Laakso, M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807233390404 · Cited by 7,000
Abdominal obesity and metabolic syndrome
Després, J.-P., & Lemieux, I. (2006) · Nature · doi:10.1038/nature05488 · Cited by 4,354 · cited 1×
“These results are consistent with the notion that the hyperglycemic state of the diabetic patient or the dysglycemic state of the prediabetic patient may only represent the tip of a large atherothrombotic inflammatory iceberg most frequently found among patients with abdominal obesity and with excess visceral/ectopic…”
ResultSelf-citationDiabetes and Cardiovascular Disease: The Framingham Study
Kannel, W. B. (1979) · JAMA · doi:10.1001/jama.1979.03290450033020 · Cited by 2,936
Metabolic Syndrome and Risk of Incident Cardiovascular Events and Death
Gami, A. S., Witt, B. J., Howard, D. E., Erwin, P. J., Gami, L. A., Somers, V. K., & Montori, V. M. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.09.032 · Cited by 1,888
Ridker, P. M., Buring, J. E., Rifai, N., & Cook, N. R. (2007) · JAMA · doi:10.1001/jama.297.6.611 · Cited by 1,814
Graham (2007) · doi:10.1097/01.hjr.0000277983.23934.c9 · Cited by 1,647
Grundy, S. M., Cleeman, J. I., Daniels, S. R., Donato, K. A., Eckel, R. H., Franklin, B. A., Gordon, D. J., Krauss, R. M., Savage, P. J., Smith, S. C., et al. (2005) · Cardiology in Review · doi:10.1097/01.crd.0000380842.14048.7e · Cited by 1,600
Assmann, G., Cullen, P., & Schulte, H. (2002) · Circulation · doi:10.1161/hc0302.102575 · Cited by 1,541 · cited 1×
“In this regard, available algorithms such as those proposed by Framingham (62) or by the PROCAM (63) study are recommended.”
MethodReduction in Weight and Cardiovascular Disease Risk Factors in Individuals With Type 2 Diabetes
The Look AHEAD Research Group (2007) · Diabetes Care · doi:10.2337/dc07-0048 · Cited by 1,522
Alexander, C. M., Landsman, P. B., Teutsch, S. M., & Haffner, S. M. (2003) · Diabetes · doi:10.2337/diabetes.52.5.1210 · Cited by 1,475 · cited 1×
“However, available evidence also suggests that the absence/presence of the metabolic syndrome could substantially modulate the CVD risk even among patients with type 2 diabetes (39,40).”
BackgroundRoss, R., Dagnone, D., Jones, P. J. H., Smith, H., Paddags, A., Hudson, R., & Janssen, I. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-2-200007180-00008 · Cited by 1,435
Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia
Després, J.-P., Golay, A., & Sjöström, L. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa044537 · Cited by 1,392
Self-citationGrundy, S. M., Pasternak, R., Greenland, P., Smith, S., & Fuster, V. (1999) · Circulation · doi:10.1161/01.cir.100.13.1481 · Cited by 1,315
The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56)
STEVENS, R. J., KOTHARI, V., ADLER, A. I., & STRATTON, I. M. (2001) · Clinical Science · doi:10.1042/cs20000335 · Cited by 1,084 · cited 1×
“Of course, the presence of classical risk factors such as dyslipidemia and hypertension will increase the cardiovascular risk associated with a given hyperglycemic state (38).”
BackgroundAmerican College of Endocrinology Position Statement on the Insulin Resistance Syndrome
Einhorn, D. (2003) · Endocrine Practice · doi:10.4158/ep.9.s2.5 · Cited by 1,066 · cited 1×
“In order to hopefully clear such confusion, the American College of Endocrinology/American Association of Clinical Endocrinologists reaffirmed in 2006 (14) their 2003 ACE Insulin Resistance Syndrome (IRS) statement (15).”
BackgroundOrchard, T. J., Temprosa, M., Goldberg, R., Haffner, S., Ratner, R., Marcovina, S., Fowler, S., & for the Diabetes Prevention Program Research Group (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-8-200504190-00009 · Cited by 948
Lemieux, I., Pascot, A., Couillard, C., Lamarche, B., Tchernof, A., Alméras, N., Bergeron, J., Gaudet, D., Tremblay, G., Prud’homme, D., et al. (2000) · Circulation · doi:10.1161/01.cir.102.2.179 · Cited by 937 · cited 1×
“On the basis of these results, we have proposed that among the clinical tools used to diagnose the metabolic syndrome, the measurement of ‘hypertriglyceridemic waist’ (elevated waist circumference combined with increased triglyceride levels) could represent a simple but important clinical phenotype which should be inc…”
MethodSelf-citationResponse of blood lipids to exercise training alone or combined with dietary intervention
LEON, A. S., & SANCHEZ, O. A. (2001) · Medicine and Science in Sports and Exercise · doi:10.1097/00005768-200106001-00021 · Cited by 662
Global guideline for type 2 diabetes: recommendations for standard, comprehensive, and minimal care
IDF Clinical Guidelines Task Force (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2006.01918.x · Cited by 433
Arnaud, C., Burger, F., Steffens, S., Veillard, N. R., Nguyen, T. H., Trono, D., & Mach, F. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000163840.63685.0c · Cited by 247
Cited by
Pathophysiology of human visceral obesity: an update
Tchernof, A., & Després, J.-P. (2013) · Physiological Reviews · doi:10.1152/physrev.00033.2011 · Cited by 2,583
“A full discussion of cardiometabolic risk is beyond the scope of the present paper and can be found in several previous reviews (109, 112, 113, 117, 232, 509).”
ResultSelf-citationCharacterizing the profile of obese patients who are metabolically healthy
Primeau, V, Coderre, L., Karelis, A. D., Brochu, M., Lavoie, M.-E., Messier, V, Sladek, R., & Rabasa-Lhoret, R. (2011) · International Journal of Obesity · doi:10.1038/ijo.2010.216 · Cited by 637
Skeletal muscle predicts ventilator-free days, ICU-free days, and mortality in elderly ICU patients
Moisey, L. L., Mourtzakis, M., Cotton, B. A., Premji, T., Heyland, D. K., Wade, C. E., Bulger, E., Kozar, R. A., & for the Nutrition and Rehabilitation Investigators Consortium (NUTRIC) (2013) · Critical Care · doi:10.1186/cc12901 · Cited by 495
Metabolically Healthy Obesity: Criteria, Epidemiology, Controversies, and Consequences
Tsatsoulis, A., & Paschou, S. A. (2020) · Current Obesity Reports · doi:10.1007/s13679-020-00375-0 · Cited by 256
Xia, C., Li, R., Zhang, S., Gong, L., Ren, W., Wang, Z., & Li, Q. (2012) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2012.83 · Cited by 169
Metadata
- Authors
- Després, J.-P., Cartier, A., Côté, M., & Arsenault, B. J.
- Venue
- Annals of Medicine
- Publisher
- Informa UK Limited
- Published
- 2008-01
- Volume
- 40
- Issue
- 7
- Pages
- 514-523
- ISSN
- 0785-3890 (ISSN-L)
- 1365-2060
- OpenAlex
- W2048592428
- Cited by
- 93
- References
- 21
- FWCI
- 5.23
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.